Poor Allergan chose the wrong drug. Looking at
Post# of 148305
(Total Views: 643)
Posted On: 08/11/2019 2:32:49 AM
Poor Allergan chose the wrong drug.
Looking at the HIV studies, leronlimab beats cenicriviroc hands down with less side effects. Cenicriviroc's method of action is similar to maraviroc and like maraviroc it seems to mute down an effective immune response. Because of this I would expect a superior response from leronlimab in NASH.
Looking at the HIV studies, leronlimab beats cenicriviroc hands down with less side effects. Cenicriviroc's method of action is similar to maraviroc and like maraviroc it seems to mute down an effective immune response. Because of this I would expect a superior response from leronlimab in NASH.
(4)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼